CRON.TO - Cronos Group Inc.
| Previous Close | 8.55 |
| Open | 8.53 |
| Bid | 8.63 x 0 |
| Ask | 8.75 x 0 |
| Day's Range | 8.38 - 8.74 |
| 52 Week Range | 5.82 - 20.72 |
| Volume | 551,119 |
| Avg. Volume | 889,229 |
| Market Cap | 3.031B |
| Beta (5Y Monthly) | 1.91 |
| PE Ratio (TTM) | 3.21 |
| EPS (TTM) | 2.71 |
| Earnings Date | Aug. 06, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.32 |
- Motley Fool
Better Buy: Aurora Cannabis vs. Cronos Group
One has seen a roller-coaster ride and is now rising from the ashes; the other has always played it safe. Which pot stock is a better bet?
- The Motley Fool
2 Growth Stocks I’m Buying When the Economy Reopens
It's time for undervalued growth stocks like Canada Goose (TSX:GOOS)(NYSE:GOOS) and Cronos Group Inc (TSX:CRON)(NASDAQ:CRON).The post 2 Growth Stocks I'm Buying When the Economy Reopens appeared first on The Motley Fool Canada.
- Motley Fool
Why the Next Market Crash Could Happen This Month
There's a disconnect today between how the markets are performing and the strength of the overall economy. Even though tens of millions of Americans are collecting unemployment benefits and the coronavirus pandemic is nowhere near over, the markets have continued to rally.
- The Motley Fool
HEXO Finds a New Market: Should Cannabis Investors Celebrate?
HEXO has scored a stock price-boosting deal in Israel, but investors should be cautiously optimistic.The post HEXO Finds a New Market: Should Cannabis Investors Celebrate? appeared first on The Motley Fool Canada.
- Motley Fool
2 Top Stocks for Retirees
First up is General Mills (NYSE: GIS). While some industries' revenues evaporated, General Mills accelerated its growth. For fiscal 2020, the General Mills pet food segment grew 18%, tripling the overall company's pace, and there is reason to believe that can continue.
- GlobeNewswire
Cronos Group Inc. to Hold 2020 Second Quarter Earnings Conference Call on August 6, 2020
Cronos Group’s senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations. The webcast of the call will be archived for replay on the Company’s website.
- Motley Fool
Which of These 2 Ultra-Growth Stocks Is Best?
The best defense during a market downturn is usually a good offense. Here are two high-growing cannabis companies that are likely to continue their momentum.
- Motley Fool
2 Marijuana Stocks With the Most Cash in 2020
At a time when cash is king, which cannabis company is better suited to cover its losses without the expense of diluting shareholders?
- The Motley Fool
Big Tobacco Is Betting $2 Billion on This Pot Stock
Tobacco giant Altria Group (NYSE:MO) is betting billions that pot producer Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) will produce big gains.The post Big Tobacco Is Betting $2 Billion on This Pot Stock appeared first on The Motley Fool Canada.
- GlobeNewswire
Cronos Group Inc. Announces Results of 2020 Annual and Special Meeting of Shareholders
Each of the directors listed as a nominee in the Company’s proxy statement dated April 28, 2020 (the “Proxy Statement”) was elected as a director of the Company, with each director receiving in excess of 97.10% of the votes cast in favor of his or her election. The Company also announced today that the shareholders have approved a special resolution authorizing the Company to make an application for the continuance of the Company from the laws of the Province of Ontario to the laws of the Province of British Columbia, as further described in the Proxy Statement (the “Continuance”).
- Motley Fool
2 Cannabis Stocks That Should Survive the COVID-19 Crisis
In most places, the marijuana industry was deemed essential amid widespread lockdowns -- which is why revenue is pouring in for the sector. Then, there are Cronos Group (NASDAQ: CRON) and Aphria (NASDAQ: APHA), which are focused on staying afloat with their strong balance sheets. Its work on producing cannabinoids more cheaply and efficiently through biosynthesis with its partner Ginkgo Bioworks is impressive.
- Simply Wall St.
Who Has Been Buying Cronos Group Inc. (TSE:CRON) Shares?
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
- The Motley Fool
Got $12,000? Buy These 3 Stocks Right Now
Aritzia Inc. (TSX:ATZ) is one of the three growth stocks I suggest to buy for future gains.The post Got $12,000? Buy These 3 Stocks Right Now appeared first on The Motley Fool Canada.
- The Motley Fool
Cronos (TSX:CRON) Stock: $0 or $30?
Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) stock has been a wild ride, but if you're patient, the company could quickly triple your investment.The post Cronos (TSX:CRON) Stock: $0 or $30? appeared first on The Motley Fool Canada.
- Zacks
Is Cronos Group (CRON) Stock Outpacing Its Medical Peers This Year?
Is (CRON) Outperforming Other Medical Stocks This Year?
- Motley Fool
Why Aurora Cannabis, HEXO, Cronos Group, and Other Cannabis Stocks Surged Today
Marijuana stocks soared on Monday, as investors grew more optimistic about the cannabis industry. Many investors view the stock market as expensive after its recent rally off its lows in March, and it's possible that bargain hunters are setting their sights on the beleaguered marijuana industry.
- The Motley Fool
2 Pot Stocks to Buy in June
This is the best time to buy promising pot stocks like HEXO Corp (TSX:HEXO)(NYSE:HEXO) and Cronos Group Inc (TSX:CRON)(NASDAQ:CRON).The post 2 Pot Stocks to Buy in June appeared first on The Motley Fool Canada.
- Yahoo Finance
Canopy Growth CEO says new data on cannabis beverages show they can be bigger than hard seltzer
Despite recent troubles, Canopy Growth is optimistic its cannabis beverages can dwarf the growth of hard seltzers.
- Zacks
Cronos Group's Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Cronos Group.
- GlobeNewswire
Cronos Group Inc. Announces Conference Participation for June 2020
The webcasts will be available on the Investors section of the Company’s website at ir.thecronosgroup.com/events-presentations. Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.
- The Motley Fool
Turn $1,000 Into $4,000 With This Pot Stock
Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a pot stock that trades at a big discount to its cash balance. Now is the time to strike.The post Turn $1,000 Into $4,000 With This Pot Stock appeared first on The Motley Fool Canada.
- Zacks
Cronos (CRON) Looks Good: Stock Adds 8.1% in Session
Cronos (CRON) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
- The Motley Fool
If You Invested $1,000 in Cronos IPO, You Would Have Returned a Staggering $85,000 Today
Is Cronos stock a buy right now?The post If You Invested $1,000 in Cronos IPO, You Would Have Returned a Staggering $85,000 Today appeared first on The Motley Fool Canada.
- Motley Fool
Better Marijuana Stock: Aurora Cannabis vs. Cronos Group
Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 results earlier this month that were below expectations. Which of these two marijuana stocks is the better pick going forward?
- Motley Fool
Why Marijuana Stock Cronos Group Shot 8% Higher on Friday
The stock of Cronos Group (NASDAQ: CRON) ended the week on a high note, rising more than 8% on Friday to outpace the gains of the broader market. Cronos has a major CBD asset in its Lord Jones product line. Although the results of the study, conducted by researchers at the University of Lethbridge in Canada, were published last month, they are only now hitting the news media and getting on the radar of investors.
